1/30
Comprehensive vocabulary flashcards covering the pathophysiology, clinical presentations, diagnostics, and pharmacologic management of chronic musculoskeletal conditions including osteoarthritis, rheumatoid arthritis, osteoporosis, and hip fractures.
Cortical (compact) bone
A dense, strong outer layer of bone that provides structural support and resists bending and twisting forces.

Cancellous (spongy) bone
A porous internal bone structure organized along lines of stress containing bone marrow and a network of supporting trabeculae, especially prominent in vertebrae.
Osteoclasts
Specialized bone cells responsible for the breakdown and reabsorption of old bone tissue during bone remodeling.
Osteoblasts
Bone-forming cells responsible for synthesizing and building new bone tissue.
Osteocytes
Mature bone cells that maintain existing bone matrix and coordinate cellular responses to mechanical stress.
Osteoarthritis (OA)
A joint disease marked by progressive degeneration and failed repair of joint tissues, resulting in articular cartilage breakdown, joint-space narrowing, and altered mechanical forces.
Subchondral sclerosis
The thickening and hardening of bone immediately underlying articular cartilage in response to abnormal mechanical loading in osteoarthritis.
Osteophytes
Bony outgrowths or spurs that develop at joint margins in response to joint damage and altered mechanical stress.
Heberden nodes
Bony enlargements that form at the distal interphalangeal (DIP) joints of the fingers in individuals with osteoarthritis.

Bouchard nodes
Bony enlargements that develop at the proximal interphalangeal (PIP) joints of the hands in osteoarthritis.
Rheumatoid arthritis (RA)
A systemic autoimmune inflammatory disease characterized by chronic immune-mediated inflammation of the synovium, symmetric polyarthritis, joint destruction, and systemic manifestations.
Pannus
An abnormal, invasive mass of thickened inflammatory synovial tissue that covers and erodes articular cartilage and subchondral bone in rheumatoid arthritis.
BoutonniĆØre deformity
A classic hand deformity in rheumatoid arthritis characterized by flexion of the proximal interphalangeal (PIP) joint accompanied by hyperextension of the distal interphalangeal (DIP) joint.

Swan neck deformity
A finger deformity associated with rheumatoid arthritis characterized by hyperextension of the proximal interphalangeal (PIP) joint and flexion of the distal interphalangeal (DIP) joint.
Osteoporosis
A skeletal disorder characterized by low bone mass and microarchitectural deterioration of bone tissue caused by bone resorption exceeding bone formation, leading to increased bone fragility.
Dual-energy X-ray absorptiometry (DXA scan)
A diagnostic imaging technique used to quantify bone mineral density (BMD), commonly evaluated at the hip and lumbar spine to screen for and diagnose osteoporosis.
T-score
A diagnostic metric comparing a patient's bone mineral density to a young adult healthy reference population, where normal is >ā1.0, osteopenia is ā1.0Ā toĀ ā2.5, and osteoporosis is <ā2.5.
Kyphosis
An excessive forward rounding and curvature of the thoracic spine, commonly resulting from asymptomatic or symptomatic osteoporotic vertebral compression fractures.

Fragility fracture
A fracture occurring from minimal trauma or a low-energy impact (such as a fall from standing height), commonly involving the vertebrae, hip, or wrist.
Acetaminophen
A non-opioid analgesic and antipyretic that reduces central prostaglandin synthesis to manage mild-to-moderate musculoskeletal pain, limited to a maximum dose of 4000mg/24hr due to risks of hepatotoxicity.
Nonsteroidal anti-inflammatory drugs (NSAIDs)
A medication class that inhibits cyclooxygenase (COX) enzymes to suppress prostaglandin synthesis, providing analgesic and anti-inflammatory effects but carrying risks of gastrointestinal ulceration, acute kidney injury, and elevated blood pressure.
Diclofenac (Voltaren Gel)
A topical nonsteroidal anti-inflammatory drug used for localized pain relief in superficial osteoarthritis (e.g., knees, hands) that minimizes systemic GI, renal, and cardiovascular drug exposure.
Celecoxib
A selective COX-2 inhibitor NSAID that diminishes inflammatory prostaglandin production without inhibiting gastroprotective COX-1, while still carrying risks of fluid retention, elevated blood pressure, and cardiovascular events.
Prednisone
A glucocorticoid that alters inflammatory gene expression and suppresses immune cascades, prescribed for rapid, short-term symptom suppression during acute rheumatoid arthritis flares or as bridging therapy.
Disease-modifying antirheumatic drugs (DMARDs)
Therapeutic agents (including conventional synthetic, biologic, and targeted synthetic types) that reduce pathological immune activity, slow progression of joint damage, and preserve functional joints in rheumatoid arthritis.
Methotrexate
A first-line conventional synthetic DMARD that modulates folate pathways and immune signaling; administered strictly once weekly and often supplemented with folic acid to minimize toxicity.
Etanercept
A subcutaneous biologic DMARD that selectively blocks tumor necrosis factor-alpha (TNF-α) to suppress inflammatory cascades and limit structural joint degradation in rheumatoid arthritis.
Tofacitinib
An oral targeted synthetic DMARD belonging to the Janus kinase (JAK) inhibitor class that impedes cytokine-mediated intracellular signaling in immune cells.
Alendronate
An oral bisphosphonate antiresorptive agent that suppresses osteoclast-mediated bone breakdown, which must be taken with plain water on an empty stomach with the patient remaining upright for at least 30minutes.
Deconditioning
A secondary functional decline characterized by muscle atrophy, loss of endurance, and impaired balance resulting from restricted movement and prolonged immobility following fractures or pain.
Delirium
An acute, fluctuating disturbance in attention, awareness, and cognition commonly triggered in older post-fracture patients by multiple factors including pain, medications, unfamiliar surroundings, and systemic infections.